These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
644 related articles for article (PubMed ID: 28374947)
1. Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition. Ohata T; Yokoo H; Kamiyama T; Fukai M; Aiyama T; Hatanaka Y; Hatanaka K; Wakayama K; Orimo T; Kakisaka T; Kobayashi N; Matsuno Y; Taketomi A Cancer Med; 2017 May; 6(5):1049-1061. PubMed ID: 28374947 [TBL] [Abstract][Full Text] [Related]
2. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma. Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468 [TBL] [Abstract][Full Text] [Related]
3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy. Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555 [TBL] [Abstract][Full Text] [Related]
6. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Du R; Wu S; Lv X; Fang H; Wu S; Kang J J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255 [TBL] [Abstract][Full Text] [Related]
9. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012 [TBL] [Abstract][Full Text] [Related]
10. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition. Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429 [TBL] [Abstract][Full Text] [Related]
12. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
14. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma. Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948 [TBL] [Abstract][Full Text] [Related]
15. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma. Liang J; Yao N; Deng B; Li J; Jiang Y; Liu T; Hu Y; Cao M; Hong J J Cell Physiol; 2024 May; 239(5):e31237. PubMed ID: 38468464 [TBL] [Abstract][Full Text] [Related]
16. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. Jin Y; Wang J; Han J; Luo D; Sun Z Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291 [TBL] [Abstract][Full Text] [Related]
17. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling. Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700 [TBL] [Abstract][Full Text] [Related]
18. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875 [TBL] [Abstract][Full Text] [Related]
19. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906 [TBL] [Abstract][Full Text] [Related]
20. TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation. Li X; He W; Chen X; Zhang Y; Zhang J; Liu F; Li J; Zhao D; Xia P; Ma W; Wu T; Wang H; Yuan Y Oncogene; 2024 Jun; 43(27):2063-2077. PubMed ID: 38755308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]